Figure 4From: Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha1-antitrypsin deficiency: a randomized study Mean plasma alpha 1 -PI concentration versus time curves following treatment with Prolastin-C or Prolastin: content [antigenic] assay results.Back to article page